GMDP Academy

🚀 In pharmaceutical medicine, innovation is powered by people—leaders who push boundaries, mentor others, and shape the future of healthcare.

The Global Fellowship in Medicines Development program at GMDP Academy honors these leaders, but every journey starts somewhere. The CMD program gives professionals the knowledge, skills, and global network to grow in their careers—and can be the first step toward contributing at the level of a Global Fellow.

🎥 Hear Dr. Peter Stonier discuss the Fellowship and what it means for the profession: https://youtu.be/8Htq0iv90ek

Global Fellowship in Medicines Development with Dr. Peter Stonier 👉 Learn more about the CMD program: https://gmdpacademy.org/certification-programs/certification-in-medicines-development/Discover the Global Fellows in Med...

What does it mean to be a CMD-certified professional? 💡
It means being part of a global movement to raise the standard in medicines development—one that values scientific excellence, ethical leadership, and patient-centered outcomes.

The Certification in Medicines Development (CMD)—a collaboration between GMDP Academy and King’s College London—equips professionals with the skills and mindset to lead in a rapidly changing healthcare world.

📚 From clinical trials to regulatory strategy and medical affairs, CMD professionals are shaping the future of pharmaceutical medicine.

🔗 Learn more and apply: https://gmdpacademy.org/certification-programs/certification-in-medicines-development

🧬 A Turning Point in Cancer Drug Manufacturing

After 30 years of research, scientists can now produce Taxol—a key cancer treatment—using engineered yeast instead of endangered trees and toxic chemicals. It’s a major step toward more sustainable and accessible oncology care.

For medicines development professionals, this shift highlights the growing importance of biotech and sustainable manufacturing methods.

Learn more: https://gmdpacademy.org/news/from-tree-to-lab-landmark-discovery-paves-way-for-greener-cheaper-cancer-drugs/

From Tree to Lab: Landmark Discovery Paves Way for Greener, Cheaper Cancer Drugs “Courageous leaders never know the “Impossible dream”Their strategic thinking enlightens the way to seize valuable opportunities; their passion ignites the starting spark on the road of success; and they dare to overcome tough challenges with resilience.They spread their wings and fly with the...

Lead the Future of Medicines Development — Enroll This Fall

Are you ready to level up in pharmaceutical medicine, medical affairs, regulatory, or R&D? This fall, the GMDP Academy is offering two high-impact online modules that combine global accessibility, expert faculty, and real-world application—designed specifically for busy professionals.

🔹 Module 7: Leadership in Medicines Development

Sept 29 – Nov 23, 2025 | 3–5 hrs/week

Master change management, strategic communication, and resilient leadership. Walk away with a personalized Leadership Action Plan.

🔹 Module 8: Digital Technology in Medicines Development

Sept 29 – Nov 9, 2025 (Orientation starts Sept 22) | ~5 hrs/week

Get ahead of the digital curve—learn how AI, patient-centered tech, and emerging platforms are reshaping the industry.

Why enroll?

✔ 100% Online and Globally Accessible

✔ World-Class Faculty, Speakers, and Interactive Learning

✔ Certificate of Completion from GMDP Academy

🗓 Deadline to apply: September 15, 2025

🎯 Seats are limited—secure yours today and gain a competitive edge.

👉 Start your application: https://info.gmdpacademy.org/gmdpapplication

More details available here: https://gmdpacademy.org/news/now-enrolling-lead-the-future-of-pharma-with-fall-2025-gmdp-academy-modules/

GMDP Academy Application

📢 Free Public Webinar – Open to All

Publication Ethics in an Era of Open Science- Facilitated by Chieko Kurihara

Missed today’s session? No worries—you can still join us tomorrow, June 4 at 8:00 AM EST for the second live offering!

Register here: https://us02web.zoom.us/meeting/register/nYSg1OdBSJi-FKNZiOKwzA #/registration

🧠 Learning Objectives:

✅ Understand the key principles in ethical publications

✅ Be aware of the differences among traditional journals, open access journals, peer review journals and predatory publications

✅ Understand the key principles of the Declaration of Helsinki and the Declaration of Taipei

✅ Be aware of examples of falsified publications even during the Covid-19 pandemic

Join us and gain the tools to navigate publishing with integrity in the evolving landscape of open science.



🔗 Full details here: https://gmdpacademy.org/news/publication-ethics-in-an-era-of-open-science-with-chieko-kurihara/

Publication Ethics in an Era of Open Science with Chieko Kurihara It’s a moment of introspection that all of us have encountered at some point along our professional journeys. Asking the existential question – what is our “why”?

📢 Upcoming Free Webinar – Open to the Public

Publication Ethics in an Era of Open Science

🎓 Part of Module 4 of our Certification in Medicines Development (CMD) series, offered by the GMDP Academy

Facilitated by Chieko Kurihara

In an age of open access and rapid data sharing, ethical publishing has never been more important. This open-access webinar offers a foundational look at how to publish responsibly in today’s complex research environment.

As part of the GMDP Academy’s commitment to making high-quality education accessible to a broader audience, this session is free and open to the public.

🗓️ Two Offerings – 8:00 AM EST:

• June 3 → https://us02web.zoom.us/meeting/register/xleZeiMGSbKyRZMKdUP-jg #/registration

• June 4 → https://us02web.zoom.us/meeting/register/nYSg1OdBSJi-FKNZiOKwzA #/registration

🧠 Learning Objectives:

✅ Understand the key principles in ethical publications

✅ Be aware of the differences among traditional journals, open access journals, peer review journals and predatory publications

✅ Understand the key principles of the Declaration of Helsinki and the Declaration of Taipei

✅ Be aware of examples of falsified publications even during the Covid-19 pandemic

Join us to strengthen your understanding of responsible publishing in today’s evolving scientific landscape.



Get more details here: https://gmdpacademy.org/news/publication-ethics-in-an-era-of-open-science-with-chieko-kurihara/

🚨 Missed the first session? You’ve still got one more chance!

If you couldn’t make it to the first offering of our CMD webinar on Investigator Initiated and Sponsored Studies, Trials, and Research with Dr. Kamlesh Thakker, don’t worry—there’s still time to join the second session!

📅 Next session:

🕛 May 29 at 12:00 PM ET

🔗 https://us02web.zoom.us/meeting/register/bPodfi_qS5-peXgxu88KWw

💡 In this webinar, you’ll gain practical insights into:

▪️ What IIS are and how they’re funded

▪️ How to apply for proposals

▪️ Common regulatory challenges across regions

▪️ Case studies to apply what you’ve learned

🎙️ Featuring Dr. Kamlesh Thakker, a global expert in Clinical Development, Medical Affairs, and Clinical Pharmacology with extensive leadership experience at Pfizer, Abbvie, and Sanofi.

✅ Don't miss your chance to learn from one of the best in the field.

🎤 Future leaders in drug development took the spotlight this week at GMDP Academy!

As part of our flagship certification in medicines development program, students delivered powerful group presentations on some of the most pressing challenges in the pharmaceutical industry—from AI in patient safety to diversity in clinical trials.

These presentations aren't just academic—they're an essential part of how we prepare professionals to lead with evidence, ethics, and collaboration.

👏 Well done to all groups for your insight, teamwork, and professionalism!

💡 Want to elevate your career in pharma or clinical research?

Check out all of our offerings, including the upcoming courses on:

Regulatory, Drug Safety, & Pharmacovigilance

Medical Affairs as a Strategic Business Partner

Leadership in Medicines Development

Digital Technology in Medicines Development

👉 Learn more and apply:

Individual Modules - GMDP Academy Craft Your Journey - Our modular approach allows you to delve into specific areas of interest within the field of Medicines Development.

🔍 Curious about Investigator Initiated Studies (IIS)?
Join Dr. Kamlesh Thakker for an in-depth CMD webinar on how IIS are designed, funded, and regulated—plus real-world case studies to bring it all to life.

📘 You’ll learn:
▪️ What IIS are and who funds them
▪️ How to apply for proposals
▪️ Key regulatory considerations by region
▪️ 3–4 case studies covering common IIS scenarios

👨‍⚕️ Presented by Dr. Kamlesh Thakker, a veteran in Medical Affairs and Clinical Development with leadership roles at Pfizer, Abbvie, Sanofi, and more.

🎓 Part of Module 4 of our Certification in Medicines Development (CMD) series.

🗓️ Choose your session:
👉 May 27 at 8:00 AM ET: https://us02web.zoom.us/meeting/register/Z4umJLG_RlyULVsvhTpufg
👉 May 29 at 12:00 PM ET: https://us02web.zoom.us/meeting/register/bPodfi_qS5-peXgxu88KWw

🚨 New Law in Montana Sparks Global Ethics Debate

Montana now allows clinics to sell experimental treatments after just Phase I trials—without FDA approval. This bold move is raising urgent questions for medicines development professionals worldwide. 🌍💊

For GMDP Academy learners, it’s a real-world test case for everything from regulatory science to patient autonomy. Are we ready for this shift?

📚 Dive into the implications across Modules 4, 5 & 7.

Montana’s Bold Bet on Experimental Medicine: Implications for Global Medicines Development Professionals “Courageous leaders never know the “Impossible dream”Their strategic thinking enlightens the way to seize valuable opportunities; their passion ignites the starting spark on the road of success; and they dare to overcome tough challenges with resilience.They spread their wings and fly with the...

💡 New CMD Webinar Alert!

Join us for Investigator Initiated and Sponsored Studies, Trials, and Research with Dr. Kamlesh Thakker, an industry leader with decades of experience in Medical Affairs, Clinical Development, and Clinical Pharmacology.

📚 In this session, you’ll explore:

🔹 What Investigator Initiated Studies (IIS) are and how they work

🔹 Who typically sponsors and funds them

🔹 The process for applying and getting approval

🔹 Real-world case studies, with insight into regulatory compliance by region

🎓 Part of our Certification in Medicines Development (CMD) Module 4 series.

📅 Two offerings available:

🔗 May 27 at 8:00 AM ET → https://us02web.zoom.us/meeting/register/Z4umJLG_RlyULVsvhTpufg

🔗 May 29 at 12:00 PM ET → https://us02web.zoom.us/meeting/register/bPodfi_qS5-peXgxu88KWw